Departmental Papers (Dental)

Document Type

Journal Article

Date of this Version

11-2003

Publication Source

Journal of Investigative Dermatology

Volume

121

Issue

5

Start Page

1005

Last Page

1012

DOI

10.1046/j.1523-1747.2003.12564.x

Abstract

Keloids are an excessive accumulation of extracellular matrix. Although numerous studies have shown elevated plasminogen activator inhibitor-1 (PAI-1) levels in keloid fibroblasts compared with those of normal skin. Their specific mechanisms involved in the differential expression of PAI-1 in these cell types. In this study, the upregulation of PAI-1 expression is demonstrated in keloid tissues and their derived dermal fibroblasts, attesting to the persistence, if any, of fundamental differences between in vivo and in vitro paradigms. We further examined the mechanisms involved in hypoxia-induced regulation of PAI-1 gene in dermal fibroblast derived from keloid lesions and associated clinically normal peripheral skins from the same patient. Primary cultures were exposed to an environmental hypoxia or desferroxamine. We found that the hypoxia-induced elevation of PAI-1 gene appears to be regulated at both transcriptional and post-transcriptional levels in keloid fibroblasts. Furthermore, our results showed a consistent elevation of HIF-1α protein level in keloid tissues compared with their normal peripheral skin controls, implying a potential role as a biomarker for local skin hypoxia. Treatment with antisense oligonucleotides against hypoxia-inducible factor 1α (HIF-1α) led to the downregulation of steady-state levels of PAI-1 mRNA under both normoxic and hypoxic conditions. Conceivably, our results suggest that HIF-1α may be a novel therapeutic target to modulate the scar fibrosis process.

Comments

At the time of publication, author Qunzhou Zhang was affiliated with the Charles R. Drew Univ. Med. and Sci.. Currently, (s)he is a faculty member at the School of Medical Dentistry at the University of Pennsylvania.

At the time of publication, author Anh D. Le was affiliated with the Charles R. Drew Univ. Med. and Sci., and the University of Southern California, School of Dentistry. Currently, (s)he is a faculty member at the School of Medical Dentistry at the University of Pennsylvania.

Keywords

Antisense, Desferroxamine, Half-life, HIF-1α, Hypoxia, deferoxamine, iron derivative, plasminogen activator inhibitor 1, adult, article, cell culture, clinical article, controlled study, environmental exposure, female, fibroblast, gene expression, human, human cell, human tissue, hypoxia, in vitro study, in vivo study, keloid, male, priority journal, regulatory mechanism, skin culture, transcription initiation, upregulation

Share

COinS
 

Date Posted: 10 February 2023

This document has been peer reviewed.